Hospital participation in cancer drug study

hospital participation in cancer drug study The prevention of adenomas of the colon with eflornithine and sulindac (PACES) clinical study, with supp...


hospital participation in cancer drug study
The prevention of adenomas of the colon with eflornithine and sulindac (PACES) clinical study, with support from the National Cancer Institute (NCI), more than 1,500 patients nationwide are enrolling their treatment for colon cancer recently …
Read more on Access North Georgia

Leave a Reply